Keywords:
MRI, Contrast agents, Liver, MR physics, MR, Contrast agent-intravenous, Quality assurance, Retrospective, Not applicable, Performed at one institution
Authors:
A. Pratesi1, S. Covizzoli2, S. Chiti2, D. Ermini2; 1Siena/IT, 2Florence/IT
DOI:
10.26044/ecr2020/C-06298
References
[1] AIFA - Agenzia Italiana del Farmaco (2018)
[2] Huh J. et al., Troubleshooting Arterial-Phase MRI of Gadoxetate Disodium-Enhanced Liver, Korean Journal of Radiology, 16(6): 1207–1215 (2015)
[3] Haradome H. et al., Can MR fluoroscopic triggering technique and slow rate injection provide appropriate arterial phase images with reducing artifacts on Gadoxetic acid–DTPA (Gd-EOB-DTPA) - enhanced Hepatic MR imaging?, Journal of Magnetic Resonance Imaging 32:334–340 (2010)
[4] Zhang H. et al., 3D Contrast-Enhanced MR Angiography, Journal of Magnetic Resonance Imaging 25:13–25 (2007)
[5] Deshmane A. et al., Parallel MR Imaging, JMRI 36:55-72 (2012).
[6] Breuer et al. Controlled Aliasing in Volumetric Parallel Imaging (2D CAIPIRINHA), Magnetic Resonance in Medicine 55:549–556 (2006)
[7] Chandarana H. et al., Respiratory Motion-Resolved Compressed Sensing Reconstruction of Free-Breathing Radial Acquisition for Dynamic Liver Magnetic Resonance Imaging; 50(11):749-56 PUB MED (2015)
[8] Mann M. R. et al., CS-VIBE – a Breakthrough in Ultrafast Dynamic Breast MRI, MAGNETOM Flash (68) 2/(2017)